Highly stable Aza-BODIPY dyes for near-infrared-II PAI/FLI guided efficient tumor photothermal therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Photoacoustic and Ultrasonic Imaging
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Advanced optical imaging technology in the near infrared window for cell tracking in vivo10.1016/j.ccr.2024.216178 ↗
2. Responsive optical probes for deep-tissue imaging: photoacoustics and second near-infrared fluorescence10.1016/j.addr.2021.03.008 ↗
3. Chemigenetic far-red labels and Ca2+ indicators optimized for photoacoustic imaging10.1021/jacs.4c07080 ↗
4. Recent advances in NIR-II fluorescence/photoacoustic dual-modality imaging probes10.1016/j.ccr.2024.215907 ↗
5. Bioresponsive fluorescent probes active in the second near-infrared window10.1002/ird3.10 ↗
6. First-in-human orbital tumor surgery guided by near-infrared II window fluorescence imaging: a feasibility study
7. An activatable phototheranostic nanoplatform for tumor specific NIR-II fluorescence imaging and synergistic NIR-II photothermal-chemodynamic therapy10.1002/smll.202206053 ↗
8. Anti-quenching NIR-II J-qggregates of benzo[c]thiophene fluorophore for highly efficient bioimaging and phototheranostics
9. 2, 1, 3-Benzothiadiazole derivative small molecule fluorophores for NIR-II bioimaging
10. J-aggregation strategy toward potentiated NIR-II fluorescence bioimaging of molecular fluorophores
11. Transmissible H-aggregated NIR-II fluorophore to the tumor cell membrane for enhanced PTT and synergistic therapy of cancer10.1186/s40580-022-00352-4 ↗
12. Pyrrolopyrrole aza-BODIPY-based NIR-II fluorophores for in vivo dynamic vascular dysfunction visualization of vascular-targeted photodynamic therapy10.1016/j.biomaterials.2023.122130 ↗
13. The acceleration of BODIPY dye-sensitized photocatalytic hydrogen production in aqueous ascorbic acid solutions using alkyl-chain formed second coordination sphere effects10.1039/D3TA03682K ↗
14. Julolidinyl aza-BODIPYs as NIR-II fluorophores for the bioimaging of nanocarriers10.1016/j.apsb.2024.04.002 ↗
15. Utilizing intramolecular photoinduced electron transfer to enhance photothermal tumor treatment of aza-BODIPY-based near-infrared nanoparticles10.1021/acsami.8b03568 ↗
16. Highly stable and multifunctional aza-BODIPY-based phototherapeutic agent for anticancer treatment10.1021/acsami.8b18669 ↗
17. Renal-clearable organic probes from D-A-D type aza-BODIPY fluorophores for multiphoton deep-brain imaging
18. Discovery of BODIPY J-aggregates with absorption maxima beyond 1200 nm for biophotonics10.1126/sciadv.add5660 ↗
19. Halogenated aza‐BODIPY for imaging‐guided synergistic photodynamic and photothermal tumor therapy10.1002/adhm.201800606 ↗
20. A novel polymer enabled by polymerized small molecule strategy for tumor photothermal and photodynamic therapy10.1186/s12951-023-02272-9 ↗
21. Highly stable organic photothermal agent based on near-infrared-II fluorophores for tumor treatment10.1186/s12951-021-00782-y ↗
22. Targeted delivery of organic small-molecule photothermal materials with engineered extracellular vesicles for imaging-guided tumor photothermal therapy10.1186/s12951-023-02133-5 ↗
23. Evolution of aza-BODIPY dyes-a hot topic
24. Discovery of subcellular-targeted aza-BODIPY photosensitizers for efficient photodynamic antitumor therapy10.1021/acs.jmedchem.2c01653 ↗
25. Nitric oxide release activated near-infrared photothermal agent for synergistic tumor treatment10.1016/j.biomaterials.2021.121017 ↗
26. Versatile aza-BODIPY-based low-bandgap conjugated small molecule for light harvesting and near-infrared photodetection10.1002/inf2.12345 ↗
27. In situ self-assembled J-aggregate nanofibers of glycosylated aza-BODIPY for synergetic cell membrane disruption and type I photodynamic therapy
28. Self-assembly induced photosensitization of long-tailed heavy-atom-free BODIPY derivatives for photodynamic therapy
29. A NIR-II organic dendrimer with superb photothermal performance based on electron-donor iteration for photothermal immunotherapy10.1002/adma.202409041 ↗
30. H-dimeric nanospheres of amphipathic squaraine dye with an 81.2% photothermal conversion efficiency for photothermal therapy
31. A self-degradable nanostructured phthalocyanine assembly with high photothermal efficacy to enhanced biosecurity in photothermal therapy10.1016/j.cej.2023.145921 ↗
32. A cyanine with 83.2% photothermal conversion efficiency and absorption wavelengths over 1200 nm for photothermal therapy10.1002/adhm.202304421 ↗
33. Near-infrared light-driven nanoparticles for cancer photoimmunotherapy by synergizing immune cell death and epigenetic regulation
34. Emerging nitric oxide gas-assisted cancer photothermal treatment10.1002/EXP.20230163 ↗
35. A borondifluoride-complex-based photothermal agent with an 80% photothermal conversion efficiency for photothermal therapy in the NIR-II window10.1002/anie.202107836 ↗
36. Anionic solid solution MXene for low-dosage NIR-II tumor photothermal therapy10.1002/adfm.202305965 ↗
37. Readily constructed squaraine J-aggregates with an 86.0% photothermal conversion efficiency for photothermal therapy
38. Near-infrared light-driving organic photothermal agents with an 88.9% photothermal conversion efficiency for image-guided synergistic phototherapy10.1002/adhm.202400201 ↗
39. Noninvasive ROS imaging and drug delivery monitoring in the tumor microenvironment10.1016/j.biomaterials.2024.122633 ↗
40. An in situ self-assembled peptide derivative for inhibition of glutathione synthesis and selective enhancement of tumor radiotherapy10.1002/ird3.31 ↗
41. Gd2O3/b-TiO2 composite nanoprobes with ultra-high photoconversion efficiency for MR image-guided NIR-II photothermal therapy10.1002/EXP.20220014 ↗